Research areas

The Department of Internal Medicine III is one of the most research-intensive departments at Ulm University Medicine. The main areas of research include

• Deciphering genetic defects and investigating their clinical significance in leukaemias, myelodysplastic syndromes, myeloproliferative diseases, malignant lymphomas and multiple myeloma
• Molecular haematopoiesis, mechanisms of leukaemogenesis
• Tumour immunology
• Molecular biology of cancer
• Clinical research with more than 100 active clinical trials
• Promotion of the researching physician through structured funding programmes

Results from the research areas have been and are published every year in high-ranking journals (publications).

The scientific projects are funded by the German Research Foundation, German Cancer Aid, Federal Ministry of Education and Research, Helmholtz Association, European Commission, Else Kröner Fresenius Foundation, German José Carreras Leukaemia Foundation, Wilhelm Sander Foundation and the American Leukemia and Lymphoma Society, among others. Scientists at the clinic coordinate or are involved in numerous structured research programmes, including

• Collaborative Research Centre SFB 1074"Experimental models and clinical translation in leukaemia"
• Virtual Helmholtz Centre "Understanding and overcoming resistance to apoptosis and therapy in leukaemia"
• EU project "Next Generation Sequencing for Targeted Personalised Therapy of Leukemia"
• Preclinical Comprehensive Cancer Centre - Helmholtz Alliance
• Else-Kröner Fresenius Kolleg "Stem cells, ageing and malignant transformation"